Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 25 February 2027
- Last conf. stmt
- 11 February 2026
Nuvision Biotherapies Limited
- Incorporated
- 7 April 2015 (11 years)
- Previously known as
- NU Vision Biotherapies Limited (until 8 August 2015)This list may be incomplete. See all names on Companies House
- Industry
- Manufacture of pharmaceutical preparations (21200)
- Directors
- Timothy James PreciousNoel Waters
- Owned by
- Accounts type
- Total exemption full
- Region
- East Midlands
- Address
- MedicityD6 BuildingThane RoadNottinghamNG90 6BH
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 6 active
Officer details are public data from the Companies House register.
Precious, Timothy James
Director · Appointed 26 May 2026
British
Born April 1972 (54)
Director · Appointed 19 June 2025
British
Born July 1963 (63)
Waters, Noel
Director · Appointed 19 June 2025
Irish
Born December 1957 (68)
Corporate Director · Appointed 26 November 2020
Director · Appointed 1 March 2018
Also at Twiin Holdings Limited · more companies
British
Born February 1967 (59)
Hopkinson, Andrew, Dr
Director · Appointed 20 May 2015
British
Born December 1976 (49)
Officer history (13 former)
26 May 2026
Appointed Precious, Timothy James as Director
31 March 2026
Resigned Treherne, Jonathan Mark, Dr as Director
31 December 2025
19 June 2025
Appointed Waters, Noel as Director
19 June 2025
Appointed Waters, Noel as Director
19 June 2025
Resigned Waters, Noel as Director
19 June 2025
19 May 2022
20 January 2022
28 April 2021
Resigned Cunningham-Thomas, Rosemary Louise as Director
26 November 2020
26 November 2020
Resigned Dodd, Isabel as Director
17 September 2020
19 December 2019
Appointed Cunningham-Thomas, Rosemary Louise as Director
24 May 2019
Appointed Dodd, Isabel as Director
24 May 2019
Resigned Mercia Fund Management (Nominees) Limited as Corporate Director
31 May 2018
Resigned Sykes, Caroline, Dr as Director
31 March 2018
Resigned Shaw, Helen Margaret as Director
1 March 2018
19 January 2018
Appointed Treherne, Jonathan Mark, Dr as Director
16 October 2017
14 December 2015
Resigned Branch, Matthew James, Dr as Director
14 December 2015
Resigned Allen, Claire as Director
8 July 2015
Appointed Branch, Matthew James, Dr as Director
8 July 2015
8 July 2015
Appointed Shaw, Helen Margaret as Director
8 July 2015
Appointed Mercia Fund Management (Nominees) Limited as Corporate Director
8 July 2015
Appointed Allen, Claire as Director
20 May 2015
Appointed Sykes, Caroline, Dr as Director
20 May 2015
Appointed Hopkinson, Andrew, Dr as Director
20 May 2015
7 April 2015
Ownership 4 active
People and entities with significant control, from the Companies House PSC register
Royal Charter Company
Reg. no. Rc000664
Corporate entity · Notified 6 April 2016
Holds 25–50% of voting rights
Private Limited Company By Shares
Reg. no. 09461920
Private Limited Company By Shares
Reg. no. 09775446
Corporate entity · Notified 6 April 2016
Holds 25–50% of voting rights
Private Limited Company By Shares
Reg. no. 09959377
Group structure 7 companies
Ownership group derived from the Companies House PSC register
Alevin Therapeutics Limited Owns 25–50% of shares
Forge Genetics Ltd Owns 25–50% of shares
Midx Ltd Owns 25–50% of shares
Nuvision Biotherapies Limited This company Owns 25–50% of shares
Performs Assessment Ltd Owns 25–50% of shares
Scintam Engineering Ltd Owns 25–50% of shares
Financials
Balance sheet as at 30 June 2025 · total exemption full accounts
- Net Assets
- £1,078,113
- Cash
- £928,803
- Employees
- 26
- Debt Ratio
- 25%
- Current Ratio
- 3.9x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £54,403 | £40,460 | £59,909 | £69,824 | £85,109 | £95,447 |
| Current Assets | £1,384,160 | £390,510 | £1,071,100 | £1,136,619 | £1,349,664 | £446,071 |
| Debtors | £236,260 | £145,453 | £282,700 | £313,595 | £234,671 | £212,489 |
| Cash | £928,803 | £44,293 | £645,677 | £673,293 | £1,023,660 | £165,566 |
| Creditors (< 1 year) | £355,265 | £392,627 | £161,172 | £404,322 | £237,134 | £251,509 |
| Creditors (> 1 year) | £0 | £210,000 | £22,500 | £32,500 | £1,014,055 | |
| Net Current Assets | £1,028,895 | (£2,117) | £909,928 | £732,297 | £1,112,530 | £194,562 |
| Net Assets | £1,078,113 | (£177,047) | £947,337 | £769,621 | £183,584 | £290,009 |
| Shareholder Funds | £1,078,113 | (£177,047) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 19 June 2026 | Appointment of a director | |||
| 14 April 2026 | Appointment of a director | |||
| 14 April 2026 | Termination of appointment of a director | |||
| 14 April 2026 | Confirmation statement with updates | 11 February 2026 | ||
| 7 April 2026 | Termination of appointment of a director |
Other companies in this industry
Castleford
Runcorn
Northampton
Oxford
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →